Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02674100 · ClinicalTrials.gov registry record

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

A clinical trial of Pancreatic Cancer, sponsored by University of Louisville.

Recruiting
Registry status
500
Enrollment target
16
Study locations

NCT02674100 is a study of Pancreatic Cancer that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 500 participants, above the 391-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (28% higher). The trial reports 16 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02674100, a study of Pancreatic Cancer, is actively recruiting participants, sponsored by University of Louisville.

RECRUITING
Registry status
500 participants
Enrollment target
16
Study locations

Study Summary

The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.

Conditions Studied

Pancreatic Cancer

Interventions

  • OTHER Registry

Study Locations (16)

Other

  • Centro Medico - Mexico City
  • National Taiwan University - Taipei
  • Freeman Hospital - High Heaton

Alabama

  • University of Alabama Birmingham - Birmingham

California

  • University of California San Diego - San Diego

Colorado

  • University of Colorado - Denver

Florida

  • University of South Florida - Tampa

Georgia

  • Augusta University - Augusta

Kentucky

  • University of Louisville - Louisville

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2016-01
Est. Completion 2030-01

Sponsor

University of Louisville

217 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02674100

The ClinicalTrials.gov registry entry for NCT02674100 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 391-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (28% higher). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancreatic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Registry is the first listed.

NCT02674100 reports 16 study locations spanning 14 distinct geographic areas - top geographies include Other, Alabama, California.

Frequently Asked Questions

What is clinical trial NCT02674100 about?

NCT02674100 is a clinical study titled "American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry". The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The...

What is the current status of trial NCT02674100?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2016-01. Estimated completion is 2030-01.

What conditions does trial NCT02674100 study?

This clinical trial studies the following conditions: Pancreatic Cancer.

What interventions are being tested in trial NCT02674100?

The interventions under investigation include: Registry (OTHER).

Who is sponsoring clinical trial NCT02674100?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02674100 being conducted?

This trial has 16 study locations across Alabama, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pancreatic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pancreatic Cancer

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.